Varicella Zoster Virus Infection
9
1
5
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
66.7%
-19.8% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
Herpes Virus Infections in Kidney Transplant Patients
Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study
An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years
Pharmacokinetics of Valacyclovir Oral Solution in Children
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir
Palatability Testing of a New Paediatric Formulation of Valacyclovir